Dr. Rudra Prasad Acharya

Overview

Dr. Rudra Prasad Acharya is an eminent Surgical Oncologist with over 22 years of experience, currently leading as the Director of Surgical Oncology at Paras Hospitals, Gurugram. He specializes in Minimal Invasive Surgical Oncology, Robotic Oncosurgery, and HIPEC, alongside limb salvage surgeries, marking him as a pioneer in the field of cancer treatment.

Education

Educational Background

Dr. Acharya's educational portfolio begins with an MBBS from Maharaja Krishna Chandra Gajapati (MKCG) Medical College, Berhampur, Orissa.

He further pursued an MS in General Surgery from the same institution, followed by comprehensive fellowships in Surgical Oncology, Colorectal Surgery, and HPB Oncology across renowned institutions globally.

Areas of Specialization

Dr. Acharya's expertise encompasses a wide range of oncological treatments, with particular emphasis on GI oncology, thoracic, urogynae oncology, and sarcomas.

He is highly skilled in laparoscopic and thoracoscopic management of various GI, thoracic, and urogenital malignancies, employing minimal invasive surgical techniques for better patient outcomes.

Professional Experience

His vast experience includes consulting roles in significant institutions across India, contributing to the advancement of surgical oncology.

As a leader in Surgical Oncology, he has been instrumental in the development of various oncological programs, emphasizing innovative surgical techniques and patient-centric care.

Publications and Contributions

Dr. Acharya has contributed significantly to the field of surgical oncology through numerous publications in esteemed journals and book chapters, sharing his insights and research findings to aid in the advancement of cancer treatment protocols.

Why Choose Dr. Rudra Acharya?

Opting for Dr. Acharya's expertise in oncological care ensures access to a wealth of experience, advanced surgical techniques, and a compassionate approach to treatment, underlined by his dedication to achieving the best possible outcomes for his patients. His commitment to minimally invasive surgery offers the benefits of reduced recovery times and enhanced precision in cancer treatment.